Bystolic
Bystolic is the brand name for nebivolol, a beta‑blocker used primarily in the management of hypertension. What sets Bystolic apart from other beta‑blockers is its unique mechanism, which combines selective beta‑1 adrenergic receptor blockade with nitric oxide‑mediated vasodilation. This dual action not only reduces heart rate and myocardial contractility but also promotes vasodilation, which helps lower blood pressure more effectively.
The mechanism of Bystolic involves selective inhibition of beta‑1 receptors in the heart, which leads to a decrease in cardiac output. Additionally, by stimulating the release of nitric oxide from the endothelium, Bystolic enhances vasodilation, reducing peripheral vascular resistance. This combination of effects can lead to a significant reduction in both systolic and diastolic blood pressure.
Bystolic is typically administered once daily, which is convenient for patients and can improve medication adherence. The once‑daily dosing is made possible by its long half‑life and sustained activity, ensuring that blood pressure remains controlled over a 24‑hour period. Healthcare providers will adjust the dose based on the patient's blood pressure response and any coexisting conditions.
Like all beta‑blockers, Bystolic may cause side effects such as fatigue, dizziness, or headache. Due to its vasodilatory properties, some patients might experience flushing or lightheadedness, particularly when beginning treatment. However, many of these side effects tend to subside with continued use as the body adjusts to the medication.
Overall, Bystolic offers an effective and well‑tolerated option for managing hypertension. Its innovative mechanism of combining beta‑1 blockade with nitric oxide‑mediated vasodilation provides additional benefits over traditional beta‑blockers. With proper dosing and regular monitoring, Bystolic can contribute to improved cardiovascular outcomes and a better quality of life for patients with high blood pressure.
NOTE: The above information is for marketing purposes only and is not to be construed as medical advice. Seek advice for medications from a qualified physician.
The mechanism of Bystolic involves selective inhibition of beta‑1 receptors in the heart, which leads to a decrease in cardiac output. Additionally, by stimulating the release of nitric oxide from the endothelium, Bystolic enhances vasodilation, reducing peripheral vascular resistance. This combination of effects can lead to a significant reduction in both systolic and diastolic blood pressure.
Bystolic is typically administered once daily, which is convenient for patients and can improve medication adherence. The once‑daily dosing is made possible by its long half‑life and sustained activity, ensuring that blood pressure remains controlled over a 24‑hour period. Healthcare providers will adjust the dose based on the patient's blood pressure response and any coexisting conditions.
Like all beta‑blockers, Bystolic may cause side effects such as fatigue, dizziness, or headache. Due to its vasodilatory properties, some patients might experience flushing or lightheadedness, particularly when beginning treatment. However, many of these side effects tend to subside with continued use as the body adjusts to the medication.
Overall, Bystolic offers an effective and well‑tolerated option for managing hypertension. Its innovative mechanism of combining beta‑1 blockade with nitric oxide‑mediated vasodilation provides additional benefits over traditional beta‑blockers. With proper dosing and regular monitoring, Bystolic can contribute to improved cardiovascular outcomes and a better quality of life for patients with high blood pressure.
NOTE: The above information is for marketing purposes only and is not to be construed as medical advice. Seek advice for medications from a qualified physician.
Bystolic / Nebicip
Nebivolol
Generic: NEBISTAR
Nebivolol
Generic: NEBISTAR
10mg
30 TAB
30 TAB
$36.10